Breaking News

Althea Appoints CFO

Demski responsible for developing strategies to support continued growth

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Martha J. Demski has been appointed senior vice president and chief financial officer, Althea Technologies. Ms. Demski will oversee finance, information technology, purchasing and corporate development, and will be responsible for developing strategies to support the company’s continued growth.

Rick Hancock, president of Althea Technologies, remarked, “Martha’s exceptional depth of experience in the biotechnology industry, her demonstrated strategic and operational proficiency, and her multifaceted perspective will be instrumental in supporting the further expansion of our business.”

Ms. Demski has more than 30 years of experience in both privately held and publicly traded biotechnology companies and in the financial services industry. Most recently, she served as the interim chief operating officer and chief financial officer of the Sidney Kimmel Cancer Center. She previously served as vice president and chief financial officer of Vical Inc., where she was responsible for multiple private and public financings, including an IPO. Ms. Demski has also held various positions with Bank of America, most recently as senior vice president in its U.S. Trust Division.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters